MINERAL IV Injection, compounded by Abrams Royal Pharmacy, Inc., Dallas, TX
Published September 3, 2014 · Recall initiated: December 19, 2013
Summary
FDA records drug Class I recall D-1563-2014, published September 3, 2014 and initiated December 19, 2013. Recalling firm: Abrams Royal Pharamacy; Status: Terminated; Reported quantity: 74; Lot: Lot number 11142013@74. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Non-Sterility; analytical results found product to contain Sphingomonas paucimobilis
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Abrams Royal Pharamacy
- Distributor
- Nationwide and to Canada
- Lot
- Lot number 11142013@74
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAll Unexpired Sterile Drug Products, compounded by Abrams Royal Pharmacy Inc., Dallas, TXSeptember 3, 2014
- FDALOW Potassium Cardioplegia 792 mL, Rx Only, Central Admixture Pharmacy Services, Inc., Livonia, MI 48150September 3, 2014
- FDAadenosine 90 mg in 0.9% sodium chloride/90 mL, Rx Only, Central Admixture Pharmacy Services, Inc., Livonia, MISeptember 3, 2014
- FDAMidazolam HCl 2 mg/ml in 0.9% Sodium Chloride in 30 mL PVC Vial, Rx Only. Pharmakon Pharmaceuticals, Inc.,September 3, 2014
- FDAdel Nido Cardioplegia with Lidocaine 1052.8 ml, Rx Only, Central Admixture Pharmacy Services, Inc., Livonia,September 3, 2014
- FDAMidazolam HCl 1 mg/ml in 0.9% Sodium Chloride in 50 mL and 100 mL IV bag, Rx Only. Labeled A) 50 mL, PharmakonSeptember 3, 2014
Questions about this recall
Was MINERAL IV Injection, compounded by Abrams Royal Pharmacy, Inc., Dallas, TX recalled?
Yes. FDA published recall D-1563-2014 on September 3, 2014. Reported hazard: Non-Sterility; analytical results found product to contain Sphingomonas paucimobilis
What should I do if I have this product?
Voluntary: Firm initiated · Letter